trial summary · NCT06561828
Developing Transcranial Neuromodulation Protocols for Learning and Decision-Making
Trial record from the TrialBase DB dataset, status RECRUITING, condition Normal Physiology, sponsored by National Institute on Drug Abuse (NIDA). Facts below are exported values from the current release, not inferred or edited prose.
Summary
The brief summary is the registry's published description, capped for length. Field definitions, types, and provenance rules are in the data dictionary.
Background: People with substance use disorder (SUD) often have changes in brain function that can make it difficult to control drug-seeking behavior. These changes may heighten the urge to use drugs or lessen the desire to seek nondrug-related rewards. Researchers want to know how a technique called transcranial magnetic stimulation (TMS) may cause changes in brain activity that may help people with SUD. Objective: To test TMS in healthy volunteers. Eligibility: Healthy people aged 18 to 45 years who are right-handed. Design: Participants can volunteer for up to 5 different experiments. Each experiment requires 2 to 8 clinic visits. Each visit will last 3 to 7 hours. Some visits will include TMS. A coil will be placed on the participant s head. A brief electrical current will pass through the coil to create a magnetic field. Participants may feel a tapping or pulling sensation on the skin under the coil. They may feel a twitch in their face, neck, arm, or leg muscles. Participants may be asked to tense certain muscles during TMS. Some visits will include functional magnetic resonance imaging (fMRI) scans. Participants will lie on a bed that slides into a large tube. They will perform tasks on a computer inside the tube. The fMRI will show which parts of the brain are used during each task. Participants will perform tasks on a computer. Some tasks may be done at a desk as well as during TMS and fMRI. Participants may look at images, listen to sounds, smell odors, or taste flavored liquids. Their vital signs may be monitored and their eye movements may be tracked during …
Source record: https://clinicaltrials.gov/study/NCT06561828
Facts
| registry id | NCT06561828 |
|---|---|
| primary registry | clinicaltrials-gov |
| recruitment status | RECRUITING |
| phase | EARLY_PHASE1 |
| study type | INTERVENTIONAL |
| lead condition | Normal Physiology |
| sponsor | National Institute on Drug Abuse (NIDA) |
| sponsor class | NIH |
| enrollment | 600 |
| start date | 2026-11-04 |
| primary completion | 2044-11-01 |
| completion | 2044-11-02 |
| results posted | not reported |
Conditions
- Normal Physiology
Interventions
- continuous Theta Burst Stimulation (cTBS)
- intermittent Theta Burst Stimulation (iTBS)
- sham Theta Burst Stimulation (sham TBS)
Countries
- United States
Intervention types: DEVICE
Work with this record
- Field definitions
Types, scope, and provenance rules for every exported field.
- REST API
Query the same gate-backed records programmatically.
- Evaluation sample
Download a bounded slice before buying.
- $29 API Pass
Seven days of REST and MCP access; credited toward the licence.